Related Experiment Videos
One Pill to Rule Them All: The Role of Single-Pill Combinations in Optimizing Blood Pressure Control
Kelsey B Bryant1, Benjamin D Gallagher2, Jennifer L Cluett3
1Department of Medicine, Icahn School of Medicine, Mount Sinai, 17 E 102nd St, D6-153, New York, NY, 10029, USA. kelsey.bryant@mountsinai.org.
Insights
Single-pill combinations (SPCs) improve medication adherence and reduce cardiovascular events in hypertension. Implementing these combination therapies in primary care is crucial for better blood pressure control.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypertension control in the U.S. is suboptimal, leading to preventable cardiovascular events.
- Single-pill combinations (SPCs) improve adherence and outcomes in other chronic diseases but are underused in hypertension.
- The latest AHA/ACC guideline recommends SPCs for stage 2 hypertension.
Purpose of the Study:
- To review evidence supporting SPC use in hypertension.
- To identify implementation challenges for SPCs in primary care.
- To highlight strategies and evidence gaps for integrating SPCs into routine care.
Main Methods:
- Review of existing evidence on SPC efficacy and adherence.
- Analysis of barriers to SPC implementation in clinical practice.
- Discussion of strategies for overcoming implementation challenges.
Main Results:
- SPCs offer improved adherence and reduced cardiovascular events and mortality.
- Clinical practice faces challenges in SPC adoption, including agent selection, cost, and workflow.
- Evidence gaps exist in long-term management and population-level control strategies.
Conclusions:
- SPCs are recommended for stage 2 hypertension, but uptake is limited.
- Addressing implementation barriers is key to utilizing SPCs effectively.
- Further strategies are needed to integrate SPCs for population-level blood pressure control.
Abstract:
Hypertension control in the United States (U.S.) remains suboptimal, perpetuating preventable risk for primary and secondary cardiovascular events. Single-pill combinations (SPCs) that contain two or more agents have improved adherence and outcomes in conditions such as human immunodeficiency virus (HIV) and heart failure, yet remain underused in hypertension care. Based on evidence of improved adherence and reductions in cardiovascular events and all-cause mortality, the recent AHA/ACC High Blood Pressure (BP) Guideline strongly recommends initiating SPC therapy for patients with stage 2 hypertension. However, translating recommendations into clinical practice remains challenging. Concerns regarding agent selection, safety, tolerability, cost, and long-term management, coupled with clinical inertia and workflow constraints, may limit uptake. In this Perspective, we review the evidence supporting SPC use and focus on implementation considerations relevant to primary care, highlighting strategies and evidence gaps that must be addressed to integrate SPCs into routine hypertension management and achieve population-level BP control.
Related Concept Videos
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Blood Pressure
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...